Delivery Order SPE2DB22D2211-SPE2DB25FSEFA
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 100 units. This competitively awarded, non-set-aside contract is valued at $1,510.57 with a firm fixed price structure and an ultimate completion date of August 19, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,381.25 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets in quantities of 30, with an ultimate completion date of August 7, 2025. This is a firm fixed price, non-set-aside contract with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 100 tablets of Terbinafine HCL 250 mg, valued at $4,315.23 with a firm fixed price structure. The contract, awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a competitively awarded, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,111.23 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (100 count) on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,994.33 to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (90-count) on August 22, 2025, with a completion date of August 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a pharmaceutical supply delivery under the Defense Logistics Agency's...
- The Defense Logistics Agency awarded a delivery order valued at $11,112.30 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (100-count units) with a completion date of July 31, 2025. This firm fixed-price, non-set-aside contract was awarded on July 30, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as...
- The Defense Logistics Agency awarded a $14,842.16 delivery order to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (30-count units) under a firm fixed-price contract type. The award was made on July 23, 2025, with an ultimate completion date of July 24, 2025, and does not utilize a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor providing critical medical supply support to federal healthcare...
- The Defense Logistics Agency awarded a $1,275.23 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (30-count supply) on September 17, 2025, with a completion deadline of September 18, 2025. This competitively awarded, non-set-aside contract represents a routine pharmaceutical procurement fulfilled through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical distributor, headquartered...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 15, 2025, to supply Terbinafine HCL 250 mg tablets (30-count units) to the Defense Logistics Agency's Medical Supply Chain. This competitive, non-set-aside award carries a ceiling value of $19,915.11 under a firm fixed-price delivery order, with an ultimate completion date of September 16, 2025. The product will be performed and delivered from AmerisourceBergen's Conshohocken...
- The Defense Logistics Agency awarded a delivery order valued at $4,124.22 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (100-count units). This competitively awarded, firm fixed-price delivery order was executed on July 29, 2025, with a completion deadline of July 30, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSEFADelivery Order
The Defense Logistics Agency awarded a $2,686.34 delivery order to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets in quantities of 30 units. This is a firm fixed price contract with an ultimate completion date of September 5, 2025, and represents a competitively awarded, non-set-aside procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive pharmaceutical supply vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor for military and veteran healthcare supply chains. The company maintains an extensive portfolio of federal contract awards with the Defense Logistics Agency, supplying a comprehensive range of pharmaceutical products and medical supplies including brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains. All reviewed contract awards reflect the company's capability to compete successfully in open federal procurements, with delivery orders utilizing firm fixed pricing structures to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 9/4/25 |